Skip to content
Unrated Drug recall · FDA · Published August 20, 2025

Major Pharmaceuticals Carvedilol Tablets Recall: NNCI Impurity Risk

Major Pharmaceuticals recalls 12.5 mg Carvedilol Tablets due to NNCI impurity exceeding FDA limits. Affected units may pose health risks; contact for return instructions.

🇺🇸 FDA recall #D-0594-2025DrugMajor Pharmaceuticals ›
Take action

Contact the company

Recalling firmThe Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories341 Mason Rd · La Vergne, TN 37086-3606
✎ GovInfoNow plain-language explainer

Major Pharmaceuticals is recalling 12.5 mg Carvedilol Tablets because they contain a harmful impurity (NNCI) at levels above FDA safety limits. This could potentially cause health issues if taken. Read more at govinfonow.com/recall/31862-major-pharmaceuticals-carvedilol-tablets-recall-nnci-impurity-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/31862-major-pharmaceuticals-carvedilol-tablets-recall-nnci-impurity-risk · Updated August 17, 2026 · FDA enforcement record: FDA #D-0594-2025

Cite this page

“Major Pharmaceuticals Carvedilol Tablets Recall: NNCI Impurity Risk.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/31862-major-pharmaceuticals-carvedilol-tablets-recall-nnci-impurity-risk. Based on FDA recall #D-0594-2025 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0594-2025%22&limit=1).

The FDA announced on 2025-08-20 that Major Pharmaceuticals is voluntarily recalling Carvedilol Tablets USP, 12.5 mg due to CGMP deviations resulting in N-Nitroso Carvedilol Impurity-1 levels exceeding the recommended limit. The recall affects 26,628 cartons distributed nationwide.

How to tell if you have it

  • Brand: Major Pharmaceuticals
  • Product: Carvedilol Tablets USP, 12.5 mg, 100- Tablets, (10x10) cartons
  • NDC: 0904-7307-61
  • Lot #: T05693
  • Exp. Date: 03/2026

The hazard

The recall is due to CGMP deviations where results for N-Nitroso Carvedilol Impurity-1 (NNCI) impurity were observed to be above the FDA-recommended limit of NMT 4.0 ppm.

Context

GovInfoNow's records show The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories has 14 other recalls on record since 2023-05-31. Other recent recalls of similar products include Major Chlorpromazine Tablets Recall (2025-09-12), Major Pharmaceuticals Sulfamethoxazole-Trimethoprim Recall (2025-09-02), and Major Pharmaceuticals recalls 10mg ChlorproMAZINE tablets due to impurity risk (2025-04-14). Other recent recalls of similar products include Unichem Bisoprolol/Hydrochlorothiazide Tablets Recall (2026-01-21), Breckenridge Duloxetine Capsules Recall (2026-04-21), and Zydus Mirabegron 25mg Tablets Recall (2026-08-05).

How to tell if you have this one

Check for the product name 'Carvedilol Tablets USP, 12.5 mg, 100-tablets, (10x10) cartons' with NDC 0904-7307-61 and lot number T05693.

  • Brand
    Major Pharmaceuticals
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Verify the product's NDC code (0904-7307-61) and lot number (T05693) to confirm it is recalled.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Product was distributed nationwide within the United States.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 7 days after the firm started it.

1. Firm started the recall: Aug 20, 202512. FDA classified it Class II: Aug 21, 202523. Published in FDA’s Enforcement Report: Aug 27, 202532025
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

Is this product safe to take?

The recall record states the impurity levels exceed FDA limits, so it is not safe to take as directed.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0594-2025 (August 20, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0594-2025 to see it in context.
  • Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA